97 related articles for article (PubMed ID: 7667707)
1. Cryptosporidiosis among HIV positive intravenous drug users in Malaysia.
Kamel AG; Maning N; Arulmainathan S; Murad S; Nasuruddin A; Lai KP
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):650-3. PubMed ID: 7667707
[TBL] [Abstract][Full Text] [Related]
2. Cryptosporidiosis in HIV infection.
Anand L; Brajachand NG; Dhanachand CH
J Commun Dis; 1996 Dec; 28(4):241-4. PubMed ID: 9057447
[TBL] [Abstract][Full Text] [Related]
3. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
4. [Current concepts of the epidemiology of cryptosporidiosis].
Lavdovskaia MV; Lysenko AIa
Med Parazitol (Mosk); 1993; (3):49-54. PubMed ID: 8041322
[No Abstract] [Full Text] [Related]
5. A study of chest infections in HIV seropositive patients in Kuala Lumpur.
Wood E; Cheong I; Lee C
Int J Clin Pract; 1998; 52(1):23-6. PubMed ID: 9536563
[TBL] [Abstract][Full Text] [Related]
6. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
Razali SM
Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated risk behaviour among drug users at drug rehabilitation centres.
Fauziah MN; Anita S; Sha'ari BN; Rosli BI
Med J Malaysia; 2003 Jun; 58(2):268-72. PubMed ID: 14569748
[TBL] [Abstract][Full Text] [Related]
8. A prevalence of Cryptosporidium infections among Thai HIV-infected patients.
Saksirisampant W; Eampokalap B; Rattanasrithong M; Likanonsakul S; Wiwanitkit V; Nasingkarn A; Denmasae N
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S424-8. PubMed ID: 12188446
[TBL] [Abstract][Full Text] [Related]
9. Cryptosporidium infection in HIV-seropositive and seronegative populations in southern Thailand.
Uga S; Kunaruk N; Rai SK; Watanabe M
Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):100-4. PubMed ID: 9740279
[TBL] [Abstract][Full Text] [Related]
10. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
[TBL] [Abstract][Full Text] [Related]
11. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
Portu JJ; Aldamiz-Etxebarria M; Agud JM; Arévalo JM; Almaraz MJ; Ayensa C
Addict Biol; 2002 Apr; 7(2):235-41. PubMed ID: 12006219
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of HIV-infected tuberculosis patients in Kota Bharu Hospital, Kelantan from 1998 to 2001.
Mohammad Z; Naing NN
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):140-3. PubMed ID: 15272757
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and epidemiologic characteristics of opportunistic and non-opportunistic intestinal parasitic infections in HIV positive patients in Manipur.
Anand L; Dhanachand C; Brajachand N
J Commun Dis; 1998 Mar; 30(1):19-22. PubMed ID: 9842160
[TBL] [Abstract][Full Text] [Related]
15. Cryptosporidiosis and microsporidiosis in ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus.
Tumwine JK; Kekitiinwa A; Bakeera-Kitaka S; Ndeezi G; Downing R; Feng X; Akiyoshi DE; Tzipori S
Am J Trop Med Hyg; 2005 Nov; 73(5):921-5. PubMed ID: 16282304
[TBL] [Abstract][Full Text] [Related]
16. [Human cryptosporidiosis and Cryptosporidium spp. in Haiti].
Raccurt CP; Brasseur P; Verdier RI; Li X; Eyma E; Stockman CP; Agnamey P; Guyot K; Totet A; Liautaud B; Nevez G; Dei-Cas E; Pape JW
Trop Med Int Health; 2006 Jun; 11(6):929-34. PubMed ID: 16772015
[TBL] [Abstract][Full Text] [Related]
17. [The incidence of human immunodeficiency virus type-1 (HIV-1) infection in parenteral drug users].
Aviñó Rico MJ; Hernández Aguado I; Pérez Hoyos S; García de la Hera M; Ruiz I; Bolumar Montrull F
Med Clin (Barc); 1994 Mar; 102(10):369-73. PubMed ID: 8182982
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
19. Cryptosporidiosis in HIV infected patients in Thailand.
Moolasart P; Eampokalap B; Ratanasrithong M; Kanthasing P; Tansupaswaskul S; Tanchanpong C
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):335-8. PubMed ID: 8629070
[TBL] [Abstract][Full Text] [Related]
20. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
